Evaluation of The Cycle SyncingⓇ Method: A 12-Week Virtual Clinical Trial

FLO LIVING, LLC

Status: Completed

Conditions: Hormonal Imbalance; Menstrual Symptoms; Menstrual Cycle Disorder

Treatments: Dietary Supplement: MyFLO App

Study type: Interventional

Funder types: Industry

Identifiers

NCT07286136

FLOLIV202503

Details and patient eligibility

About

This 12-week, 100% virtual single-group open-label trial evaluates the Cycle SyncingⓇ Method using the MyFLO app, MIRA hormonal monitoring, and continuous glucose monitoring to assess reduction in menstrual cycle symptom burden and hormonal regulation.

Enrollment: 60 patients

Sex: Female

Ages: 22 to 42 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Female participants aged 22 - 42 years
• Regular menstrual cycles
• Willingness and ability to comply with daily app usage and device protocols
• Access to a compatible smartphone and reliable internet connection
• Ability to attend a weekly virtual call with study personnel

Exclusion criteria

• Current pregnancy or breastfeeding
• Use of hormonal contraceptives or other medications known to alter menstrual cycle physiology
• Presence of significant comorbidities or chronic conditions that may interfere with study participation
• Any condition that, in the investigator's opinion, would make participation unsafe

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

60 participants in 1 patient group

Cycle SyncingⓇ Intervention Group

Experimental group

Description:

Participants will follow the Cycle SyncingⓇ Method daily for 12 weeks using the MyFLO app.

Treatment:

Dietary Supplement: MyFLO App